Sudbury medtech device approved for sale in India

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

IRegained, a Digital Neurotherapeutics (DTx) company that is developing advanced, innovative neuro-rehabilitation solutions to empower people with a stroke, TBI or musculoskeletal injuries, regain function and restore their quality of life, will now begin commercial operations in India. IRegained's MyHand® System will transform the lives of stroke and brain injury survivors across the Indo-Pacific region.

The company, makes the MyHand® System, which prompts patients to perform a series of hand movements that encourages a return to function that may have been lost following a stroke.

IRegained is an alumnus of our BDSP™, Life Sciences Critical Technologies & Commercialization (LSCTC) Centre of Excellence, and WiHI programs.

Read more
Arsheen Kaur
Previous

Campbellford Memorial Hospital’s new homecare program frees up 14.5 Hospital Bed-Days per Patient through a partnership with Gotcare and OBIO®
Next

ProteinQure receives regulatory clearance to initiate Phase I Trial for PQ203 in the U.S. and Canada; Granted FDA Fast Track Designation